Stoke Therapeutics, Inc. (STOK)
36.41
+0.86
(+2.42%)
USD |
NASDAQ |
Feb 27, 16:00
36.46
+0.05
(+0.14%)
After-Hours: 20:00
Stoke Therapeutics Research and Development Expense (TTM) : 117.76M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.498B |
| Krystal Biotech, Inc. | 55.08M |
| Scholar Rock Holding Corp. | 210.30M |
| Zymeworks, Inc. | 142.83M |
| Moderna, Inc. | 2.917B |